Literature DB >> 25232451

Pictures of focal nodular hyperplasia and hepatocellular adenomas.

Christine Sempoux1, Charles Balabaud1, Paulette Bioulac-Sage1.   

Abstract

This practical atlas aims to help liver and non liver pathologists to recognize benign hepatocellular nodules on resected specimen. Macroscopic and microscopic views together with immunohistochemical stains illustrate typical and atypical aspects of focal nodular hyperplasia and of hepatocellular adenoma, including hepatocellular adenomas subtypes with references to clinical and imaging data. Each step is important to make a correct diagnosis. The specimen including the nodule and the non-tumoral liver should be sliced, photographed and all different looking areas adequately sampled for paraffin inclusion. Routine histology includes HE, trichrome and cytokeratin 7. Immunohistochemistry includes glutamine synthase and according to the above results additional markers such as liver fatty acid binding protein, C reactive protein and beta catenin may be realized to differentiate focal nodular hyperplasia from hepatocellular adenoma subtypes. Clues for differential diagnosis and pitfalls are explained and illustrated.

Entities:  

Keywords:  Beta catenin; Focal nodular hyperplasia; Hepatocellular adenoma; Hepatocyte nuclear factor 1 alpha; Inflammatory hepatocellular adenoma

Year:  2014        PMID: 25232451      PMCID: PMC4163741          DOI: 10.4254/wjh.v6.i8.580

Source DB:  PubMed          Journal:  World J Hepatol


  19 in total

Review 1.  Diagnosis of focal nodular hyperplasia: not so easy.

Authors:  P Bioulac-Sage; C Balabaud; I R Wanless
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

Review 2.  Malignant transformation of liver adenoma: an analysis of the literature.

Authors:  Olivier Farges; Safi Dokmak
Journal:  Dig Surg       Date:  2010-04-01       Impact factor: 2.588

Review 3.  Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update.

Authors:  P Bioulac-Sage; C Balabaud; P Bedossa; J Y Scoazec; L Chiche; A P Dhillon; L Ferrell; V Paradis; T Roskams; V Vilgrain; I R Wanless; J Zucman-Rossi
Journal:  J Hepatol       Date:  2007-01-02       Impact factor: 25.083

4.  Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management.

Authors:  A Sa Cunha; J F Blanc; E Lazaro; L Mellottee; B Le Bail; J Zucman-Rossi; C Balabaud; P Bioulac-Sage
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

5.  Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Anne Rullier; Gaelle Cubel; Christophe Laurent; Jessica Zucman-Rossi; Charles Balabaud
Journal:  Liver Int       Date:  2008-09-18       Impact factor: 5.828

6.  Hepatocellular adenoma subtypes: the impact of overweight and obesity.

Authors:  Paulette Bioulac-Sage; Said Taouji; Laurent Possenti; Charles Balabaud
Journal:  Liver Int       Date:  2012-03-19       Impact factor: 5.828

7.  Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.

Authors:  Hervé Laumonier; Hélène Cailliez; Charles Balabaud; Laurent Possenti; Jessica Zucman-Rossi; Paulette Bioulac-Sage; Hervé Trillaud
Journal:  AJR Am J Roentgenol       Date:  2012-08       Impact factor: 3.959

8.  Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver.

Authors:  Paulette Bioulac-Sage; Sandra Rebouissou; Antonio Sa Cunha; Emmanuelle Jeannot; Sébastien Lepreux; Jean-Frédéric Blanc; Hélène Blanché; Brigitte Le Bail; Jean Saric; Pierre Laurent-Puig; Charles Balabaud; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

9.  Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Gabrielle Couchy; Brigitte Le Bail; Antonio Sa Cunha; Anne Rullier; Christophe Laurent; Jean-Frédéric Blanc; Gaelle Cubel; Hervé Trillaud; Jessica Zucman-Rossi; Charles Balabaud; Jean Saric
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

10.  Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens.

Authors:  Paulette Bioulac-Sage; Saïd Taouji; Brigitte Le Bail; Laurent Possenti; Charles Balabaud
Journal:  Int J Hepatol       Date:  2013-02-19
View more
  5 in total

Review 1.  Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature.

Authors:  Marco Di Pietropaolo; Chiara Briani; Emanuela Pilozzi; Francesco Carbonetti; Vincenzo David; Elsa Iannicelli
Journal:  J Gastrointest Cancer       Date:  2015-12

Review 2.  Hepatocellular adenoma management: advances but still a long way to go.

Authors:  Jean Frédéric Blanc; Nora Frulio; Laurence Chiche; Paulette Bioulac-Sage; Charles Balabaud
Journal:  Hepat Oncol       Date:  2015-05-15

3.  MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma.

Authors:  Gábor Lendvai; Tímea Szekerczés; Benedek Gyöngyösi; Krisztina Schlachter; Endre Kontsek; Adrián Pesti; Attila Patonai; Klára Werling; Ilona Kovalszky; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2018-11-09       Impact factor: 3.201

4.  Hepatocyte Nuclear Factor 1α-Mutated Hepatocellular Adenomas: An Atypical Presentation.

Authors:  Camila Maria Neves Sousa; Patricia Maria Miranda Gadelha; Rafaella de Sousa Cartaxo; George Washington Holanda Pedrosa; Rodrigo Schuler Honorio; José Milton de Castro Lima; Gustavo Rêgo Coelho; Clovis Rêgo Coelho
Journal:  Case Rep Gastroenterol       Date:  2017-10-30

Review 5.  Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver.

Authors:  Jiliang Feng; Ruidong Zhu; Yu Yin; Shanshan Wang; Lei Zhou; Fudong Lv; Dawei Zhao
Journal:  J Hepatocell Carcinoma       Date:  2021-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.